Support Journalism
HomeWorldOmicron variant identified in 89 countries; has doubling time between 1.5-3 days...
WorldTrending

Omicron variant identified in 89 countries; has doubling time between 1.5-3 days in high community transmission areas: WHO

thenews21bureau
By thenews21bureau

The Omicron variant has now been identified in 89 countries and is spreading significantly faster than the Delta variant in places where community transmission is high, with a doubling time between 1.5 3 days, the WHO has said.

In its ‘Enhancing Readiness for Omicron (B.1.1.529): Technical Brief and Priority Actions for Member States’ report on Friday, the World Health Organisation said that given the current available data, it is likely that Omicron will outpace Delta where community transmission occurs.

“Omicron is spreading rapidly in countries with high levels of population immunity and it remains uncertain to what extent the observed rapid growth rate can be attributed to immune evasion, intrinsic increased transmissibility or a combination of both,” it said.

“As of 16 December 2021, the Omicron variant has been identified in 89 countries across all six WHO regions. Current understanding of the Omicron variant will continue to evolve as more data becomes available,” it said.

There is consistent evidence that Omicron has a substantial growth advantage over Delta. It is spreading significantly faster than the Delta variant in countries with documented community transmission, with a doubling time between 1.5 3 days, the global health body said.

The WHO designated Omicron, or B.1.1.529 variant, as a variant of concern (VOC) on November 26 after it was first detected in South Africa.

There is still limited data on the clinical severity of Omicron. More data are needed to understand the severity profile and how severity is impacted by vaccination and pre-existing immunity, the WHO said.

The overall threat posed by Omicron largely depends on how transmissible the variant is; how well vaccines and prior infection protect against infection, transmission, clinical disease and death; how virulent the variant is compared to other variants; and how populations understand these dynamics, perceive risk and follow control measures, including public health and social measures, it said.

There is still limited available data, and no peer-reviewed evidence, on vaccine efficacy or effectiveness to date for Omicron, the WHO added.

thenews21bureau
thenews21bureau
Previous article
Factional feud within Sena out in the open as Sena leader Kadam accuses Minister Parab and Samant of trying to finish-off party
Next article
Amid Omicron scare as Christmas-New Year season nears, Mumbai civic chief tells people to adhere to norms strictly

RELATED ARTICLES

40 COMMENTS

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Must Read

spot_img

TheNews21 is India’s independent digital news and investigative platform founded by senior journalist Vivek Bhavsar. From our Mumbai newsroom, we expose corruption, analyse political power, track governance and public policy, and report on issues that directly impact citizens. Alongside investigations, we bring credible coverage of national politics, economy, foreign affairs, business, crime, and civic matters. Our journalism stands firmly on the principles of independence, accuracy, and public interest — No Fear, No Favour.

Quick Links

Popular Articles

Taiwan Seeks ‘Meaningful Dialogue’ With China

SC stays production warrant issued against comedian Munawar Faruqui in case lodged in UP for allegedly hurting religious sentiments

Facebook removes nearly 200 accounts linked to white supremacy groups

Plus 2 lecturers forum meets Principal Secretary Education over New Education policy and other issues

Maharashtra: Man sets himself ablaze outside Vidhan Bhavan in Mumbai

Maharashtra: 1 killed, 8 injured in clash between two groups in Akola; 26 people detained